524 results on '"Dicker, Frank"'
Search Results
2. Risk assessment according to IPSS-M is superior to AML ELN risk classification in MDS/AML overlap patients defined by ICC
3. AML classification in the year 2023: How to avoid a Babylonian confusion of languages
4. Indeterminate and oncogenic potential: CHIP vs CHOP mutations in AML with NPM1 alteration
5. Comment on: coagulopathy following Crotaline snakebites in northeast Florida
6. Proximally biased V(D)J recombination in the clonal evolution of IGH alleles in KMT2A::AFF1 BCP‐ALL of all age classes.
7. NPM1 mutated AML can relapse with wild-type NPM1: persistent clonal hematopoiesis can drive relapse
8. Number and variety of detected substances in a regional sample of the illicit drug supply in Saint Louis, Missouri.
9. DNMT3A mutations are over-represented in young adults with NPM1 mutated AML and prompt a distinct co-mutational pattern
10. International external quality assurance of JAK2 V617F quantification
11. P694: RISK ASSESSMENT ACCORDING TO IPSS-M IS SUPERIOR TO AML ELN 2022 RISK CLASSIFICATION IN MDS/AML PATIENTS DEFINED BY ICC – IS AN INCLUSION INTO AML TRIALS JUSTIFIED?
12. Phosphorylation-Independent Inhibition of Parathyroid Hormone Receptor Signaling by G Protein-Coupled Receptor Kinases
13. Detection of recurrent and of novel fusion transcripts in myeloid malignancies by targeted RNA sequencing
14. Treatment-free remission after third-line therapy with asciminib in chronic myeloid leukemia with an atypical e19a2 BCR::ABL1transcript and T315I mutation
15. AML and MDS Classification According to Who 2022 and International Consensus Classification: Do We Invent a Babylonian Confusion of Languages?
16. Benchmarking of Whole Genome Sequencing (WGS) and Whole Transcriptome Sequencing (WTS) As Diagnostic Tools for Determining the Mutation Status of IGHV Genes in CLL
17. Proximally Biased V(D)J Recombination and Evolution of Non-Productive Clones in B-Cell Precursor Acute Lymphocytic Leukemia with KMT2A::AFF1 Fusion Genes
18. SRSF2 mutations in 275 cases with chronic myelomonocytic leukemia (CMML)
19. A novel hierarchical prognostic model of AML solely based on molecular mutations
20. RUNX1 mutations are frequent in de novo AML with noncomplex karyotype and confer an unfavorable prognosis
21. Incidential Findings of Mutations in the PIGA Gene Are Highly Specific for the Presence of PNH Clones
22. Minimal residual disease levels assessed by NPM1 mutation–specific RQ-PCR provide important prognostic information in AML
23. Accumulation of adverse prognostic markers worsens prognosis in chronic lymphocytic leukaemia
24. Characterization of a new myeloid leukemia cell line with normal cytogenetics (CG-SH)
25. Indeterminate and oncogenic potential: CHIP vs CHOP mutations in AML with NPM1 alteration
26. Modification of the ELN Classification 2022 Refines Risk Assessment in MDS/AML Patients
27. Proposal ofmyeloid Neoplasms with MYC-Positive Double Minutes As a Distinct Entity
28. Quantification of rare NPM1 mutation subtypes by digital PCR
29. Flow cytometric identification of 76 patients with biclonal disease among 5523 patients with chronic lymphocytic leukaemia (B-CLL) and its genetic characterization
30. Trisomy 13 is strongly associated with AML1/RUNX1 mutations and increased FLT3 expression in acute myeloid leukemia
31. CD154 induces p73 to overcome the resistance to apoptosis of chronic lymphocytic leukemia cells lacking functional p53
32. Immunostimulatory oligonucleotide-induced metaphase cytogenetics detect chromosomal aberrations in 80% of CLL patients: a study of 132 CLL cases with correlation to FISH, IgVH status, and CD38 expression
33. Monoclonal B-cell lymphocytosis is closely related to chronic lymphocytic leukaemia and may be better classified as early-stage CLL
34. Biological and clinical characterization of recurrent 14q deletions in CLL and other mature B-cell neoplasms
35. Inhibitors of XIAP sensitize CD40-activated chronic lymphocytic leukemia cells to CD95-mediated apoptosis
36. Fas-ligand (CD178) and TRAIL synergistically induce apoptosis of CD40-activated chronic lymphocytic leukemia B cells
37. ZAP-70 directly enhances IgM signaling in chronic lymphocytic leukemia
38. Re: Prognostic Significance of a Short Sequence Insertion in the MCL-1 Promoter in Chronic Lymphocytic Leukemia
39. Dual Regulation of the Parathyroid Hormone (PTH)/PTH-Related Peptide Receptor Signaling by Protein Kinase C and β-Arrestins
40. Fulminant blast crisis with de novo 11q23 rearrangement in a Philadelphia-positive CML patient undergoing treatment with dasatinib
41. Evidence of clonality in cases of hypereosinophilia of undetermined significance
42. International external quality assurance of JAK2 V617F quantification
43. DNMT3A and NPM1 Double Mutated AML Is a Phenomenon of the Younger Patient and Could Represent a New Entity
44. An Unusual Presentation of Cardiogenic Shock in the Emergency Department
45. Characterization and Prognostic Impact of Multiple Productive IGHV Rearrangements in CLL
46. Patients with TP53 Disruption and IGHV Mutated Status Show Indolent Clinical Course: A Study on 1,327 Treatment-Naive CLL Cases
47. Young Man with Sore Throat, Headache, and Rash
48. DNMT3Amutations are over-represented in young adults with NPM1mutated AML and prompt a distinct co-mutational pattern
49. Development and validation of a real-time quantification assay to detect and monitor BRAFV600E mutations in hairy cell leukemia
50. Characterization of MYD88 mutated Lymphoplasmacytic Lymphoma in Comparison to MYD88 mutated Chronic Lymphocytic Leukemia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.